Education ▼

OS by PS in Metastatic Pancreatic Cancer Treatment- Data From an Exploratory Subgroup Analysis

SPECIALTY TOPICS

CURRENTLY VIEWING
Chronic Lymphocytic Leukemia

Gastrointestinal Cancer

Chronic Lymphocytic Leukemia

Novel CLL Regimens Show Promising Efficacy

Suman Kambhampati, MD, reflects on the emergence of data in chronic lymphocytic leukemia from the 2018 ASH Annual Meeting.
Read More >>

Ibrutinib/JCAR014 Combo Shows Potential in Relapsed/Refractory CLL

FDA Approves Ibrutinib Plus Obinutuzumab in Frontline CLL/SLL

Duvelisib Provides CLL Patients With a Later Line of Therapy

Targeting BCL-2 in Hematologic Malignancies

BCL-2: Mechanisms and Prevalence

View More Stories >>

View Conference Coverage

2019 Genitourinary Cancers Symposium

2019 Transplantation and Cellular Therapy Meetings

2019 Winter Lung Cancer Conference

2019 SGO Winter Meeting

2019 Gastrointestinal Cancers Symposium

Dr. Kambhampati Discusses Data from the 2018 ASH Annual Meeting in CLL

Dr. Arora on the Use of Venetoclax in CLL

Dr. Kahl on Frontline Therapy Selection in CLL

Dr. Kambhampati on Frontline Ibrutinib Plus Obinutuzumab in CLL

Dr. Seymour Discusses Rationale for MURANO Study in CLL

Dr. Hill on Resistance to BTK Inhibition in CLL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Resistance to Venetoclax in CLL

CD20-Targeted Antibodies With Novel Agents for CLL

Toxicity Management With Venetoclax for CLL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Venetoclax-Based Regimens as First-Line Therapy in CLL

The Evolving Treatment Landscape of CLL

$Relapsed/Refractory CLL: Evaluating Other Novel Agents$

Relapsed/Refractory CLL: Evaluating Other Novel Agents

$Novel Approaches to Treating Relapsed/Refractory CLL$

$Continuing Therapy in Relapsed/Refractory CLL$

$Evaluating Pharmacologic Agents in Relapsed/Refractory CLL$

CLL: Post-Ibrutinib or Chemoimmunotherapy Approaches

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Other Promising Strategies in CLL

This expert panel discussion led by William Wierda, MD, focuses on promising strategies available for the treatment of chronic lymphocytic leukemia. Dr. Wierda is joined in this discussion by Steven Coutre, MD; Matthew S. Davids, MD, MMSc; Nicole Lamanna, MD; and Shuo Ma, MD, PhD.